当前位置：
X-MOL 学术
›
Nat. Rev. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Haematological cancer: Daratumumab proves effective in patients with newly diagnosed multiple myeloma
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2018-01-16 , DOI: 10.1038/nrclinonc.2018.1 Peter Sidaway
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2018-01-16 , DOI: 10.1038/nrclinonc.2018.1 Peter Sidaway
Haematological cancer: Daratumumab proves effective in patients with newly diagnosed multiple myeloma
中文翻译：
血液学癌症：Daratumumab被证明对新诊断的多发性骨髓瘤患者有效
血液学癌症：Daratumumab被证明对新诊断的多发性骨髓瘤患者有效
更新日期：2018-01-16
Haematological cancer: Daratumumab proves effective in patients with newly diagnosed multiple myeloma, Published online: 16 January 2018; doi:10.1038/nrclinonc.2018.1
Haematological cancer: Daratumumab proves effective in patients with newly diagnosed multiple myeloma中文翻译：
血液学癌症：Daratumumab被证明对新诊断的多发性骨髓瘤患者有效
血液学癌症：Daratumumab被证明对新诊断的多发性骨髓瘤患者有效
血液癌症：Daratumumab被证明对新诊断的多发性骨髓瘤患者有效，在线发布：2018年1月16日; doi：10.1038 / nrclinonc.2018.1
血液学癌症：Daratumumab被证明对新诊断的多发性骨髓瘤患者有效
京公网安备 11010802027423号